Ed Susman

Articles

ASCO: GI Single-Agent Chemotherapy Improves Gastric Cancer Survival

January 19, 2007

ORLANDO -- Adjuvant chemotherapy with S-1, an oral prodrug of 5-fluorouracil (5-FU), improved survival compared with surgery alone, according to results of a phase III trial of 1,059 gastric cancer patients here reported here.